Tara Arvedson

Tara Arvedson, PhD, is Chief Scientific Officer at Hexagon Bio, where she leads discovery and preclinical strategy to advance novel, genetically validated oncology therapeutics. She brings over two decades of industry experience, including nearly 14 years at Amgen, where she served as Executive Director of Oncology Research. Tara is highly accomplished in target identification and validation, assay development, protein therapeutic engineering, and translating programs from discovery through IND-enabling studies. She has successfully advanced multiple molecules into clinical development and is known for her rigorous, data-driven approach. Tara previously completed a Damon Runyon Cancer Research Fellowship at UC San Diego.